NCT00183963View on ClinicalTrials.gov

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Breast Carcinoma
Interventions
DRUG

Tamoxifen

20mg

DRUG

Fulvestrant

250mg

DRUG

Fulvestrant

500 mg IM

Trial Locations (1)

90033

Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Southern California

OTHER